- Home
- JANX vs HSTM Comparison
JANX vs HSTM Comparison
Compare JANX & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | HSTM |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 661.3M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | JANX | HSTM |
|---|---|---|
| Price | $13.59 | $21.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | ★ $52.45 | $28.00 |
| AVG Volume (30 Days) | ★ 1.0M | 396.0K |
| Earning Date | 06-01-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | $10,000,000.00 | ★ $304,064,000.00 |
| Revenue This Year | N/A | $5.76 |
| Revenue Next Year | $235.70 | $4.85 |
| P/E Ratio | ★ N/A | $34.75 |
| Revenue Growth | N/A | ★ 4.26 |
| 52 Week Low | $12.12 | $19.50 |
| 52 Week High | $35.34 | $34.13 |
Technical Indicators
Market Signals| Indicator | JANX | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 52.73 |
| Support Level | $13.03 | $21.29 |
| Resistance Level | $13.79 | $22.56 |
| Average True Range (ATR) | 0.50 | 0.67 |
| MACD | 0.14 | 0.22 |
| Stochastic Oscillator | 55.56 | 49.17 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.